Operator
Hello, everyone, and welcome to NRx Pharmaceuticals, Inc.’s 2025 Annual Meeting of Stockholders. Before we get started, I would like to go over a few logistical items so you know how to participate in today’s meeting.
[Operator Instructions] The polls are now open, viewers can go to www.cstproxy.com/nrxpharma/2026, as shown in the chat box for all attendees.
At this time, I would like to now introduce Jonathan Javitt, Chairman of the Board of Directors of NRx Pharmaceuticals, Inc.
Jonathan Javitt
Co-Founder, Chief Scientist Officer, Chairman & Interim CEO
Good morning, and welcome to the NRx Pharmaceuticals 2025 Annual Meeting of Stockholders. I’m calling the meeting to order at 10:00 Eastern Daylight Time.
I’m Jonathan Javitt, Chairman of the Board of Directors of the company and one of its founders. On behalf of the Board and the executive management team of the company, we hope that you and your families are doing well. We’d like to thank all of those who have made it possible to conduct this virtual meeting, and we look forward to interacting with you today.
We also look forward to holding future meetings in person now that we have clinical facilities open and a place where we can show you what we’re doing to save lives on a daily basis.
I’m going to act as Chairman of the meeting; and Michael Abrams, our Chief Financial Officer and Corporate Treasurer, will serve as Secretary for the meeting.
Now I see that we have 18 people in attendance. If you’re a stockholder and you’d like to be able to ask questions, please
